State

US Virgin Islands product recalls

73,722 recalls have nationwide distribution and so reach US Virgin Islands. 178 additional recalls listed US Virgin Islands specifically in their distribution scope.

What the numbers show

Total: 178
Critical: 12
Severe: 39
Most recent: 2026-10-21

Of the 178 recalls naming US Virgin Islands we have scored against our rubric, 12 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 39 (22%) are Severe.

Which agencies issued them

These figures cover only the 178 recalls whose distribution notice names US Virgin Islands specifically. The 73,722 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

30876–30900 of 73900

SevereFDA (Drugs)·D-0541-2020·2019-12-11
Sanofi Recalls Zantac 150 mg Tablets Due to NDMA Impurity
Sanofi-Aventis U.S. LLC is recalling Regular Strength Zantac 150 mg tablets nationwide because an NDMA impurity was detected. This action addresses current good manufacturing practice (CGMP) deviations.
Product
Regular Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 67751-151-01.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0554-2020·2019-12-11
QuVa Pharma Recalls Fentanyl and Ropivacaine Infusions Due to Particulate Matter
QuVa Pharma is recalling specific lots of fentanyl and ropivacaine infusions due to the potential presence of glass particulate matter.
Product
fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.2% 400 mg/200 mL (2 mg/mL) in 0.9% Sodium Chloride 200 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1440-76
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0544-2020·2019-12-11
Sanofi Recalls Zantac 150 mg Tablets Due to NDMA Impurity
Sanofi-Aventis U.S. LLC is recalling Zantac 150 mg tablets nationwide because an NDMA impurity was detected in the product.
Product
Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 66715-9736-2 66715-9736-3 66715-9736-8
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0568-2020·2019-12-11
QuVa Pharma Recalls Fentanyl and Bupivacaine Infusion Due to Glass Particulates
QuVa Pharma is recalling specific lots of a fentanyl and bupivacaine infusion due to the presence of glass particulates.
Product
fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1.667 mg/mL) in 0.9% Sodium Chloride 200 mL in 250 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1436-76
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0534-2020·2019-12-11
Sanofi Recalls Zantac Tablets Due to NDMA Impurity
Sanofi is recalling Cool Mint Tablets Maximum Strength Zantac 150 mg nationwide because NDMA impurity was detected in the product.
Product
Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's: 0597-0120-06, 0597-0120-08, 0597-0120-09, 0597-0120-24, 0597-0120-38, 0597-0120-50, 0597-0120-76…
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0561-2020·2019-12-11
QuVa Pharma Recalls Fentanyl and Ropivacaine Bags Due to Glass Particulates
QuVa Pharma is recalling specific lots of fentanyl and ropivacaine injection bags due to the presence of glass particulates.
Product
fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1108-36
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0545-2020·2019-12-11
Sanofi Recalls Zantac 75 mg Tablets Due to NDMA Impurity
Sanofi-Aventis U.S. LLC is recalling Zantac 75 mg tablets nationwide because NDMA impurity was detected. The recall covers all lots of the product.
Product
Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 0597-0122-01 0597-0122-08 0597-0122-13 0597-0122-37 0597-0122-40 0597-0122-54 0597-0122-61 0597-0122-81 0597-0122-96
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0551-2020·2019-12-11
QuVa Pharma Recalls Fentanyl Syringes Due to Glass Particulate Matter
QuVa Pharma is recalling fentanyl syringes due to the potential presence of glass particulate matter. The recall is classified as FDA Class II.
Product
fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL in 35 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1099-49
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0567-2020·2019-12-11
QuVa Pharma Recalls Fentanyl Injection Bags Due to Glass Particulates
QuVa Pharma is recalling fentanyl injection bags due to the potential presence of glass particulates.
Product
fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1444-05
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0543-2020·2019-12-11
Sanofi Recalls Zantac 75 mg Due to NDMA Impurity
Sanofi is recalling Regular Strength Zantac 75 mg tablets nationwide because an NDMA impurity was detected in the product.
Product
Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 68151-2584-0.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0556-2020·2019-12-11
QuVa Pharma Recalls Fentanyl Injection Due to Glass Particulate Matter
QuVa Pharma is recalling fentanyl 100 mcg/2 mL injections because of potential glass particulate matter. The recall covers specific lots distributed nationwide.
Product
fentaNYL 100 mcg/2 mL (50 mcg/mL) Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1097-43
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-0593-2020·2019-12-11
Stryker Recalls Disposable Tourniquet Cuffs Due to Air Leak Risk
Stryker is recalling 16,380 disposable tourniquet cuffs because they may leak air, causing a loss of vascular occlusion during surgery.
Product
Color Cuff Disposable Tourniquet Cuff, 18 inch X 3 inch, 1BLA (Single Bladder), 2PRT(Dual Port) Quick Connect Connector, Product Number 5921-018-235 - Product Usage: The Stryker Disposable Tourniquet Cuff (cuff) is indicated for use in surgical procedures that require the…
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0550-2020·2019-12-11
QuVa Pharma Recalls Fentanyl and Bupivacaine Injection Due to Particulate Matter
QuVa Pharma is recalling fentanyl and bupivacaine injection bags due to the presence of particulate matter, specifically potential glass particles.
Product
fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.125% 125 mg/100 mL (1.25 mg/mL) in 0.9% Sodium Chloride Preservative Free, 100 mL in 150 Bag, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1104-36
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-0586-2020·2019-12-11
Steris Evolution Loading Car and Transfer Carriage Recall for Locking Pin Defect
Steris Corporation is recalling 237 Evolution Loading Cars and Transfer Carriages because a locking pin defect may cause the equipment to fall forward unexpectedly.
Product
Evolution Loading Car and Transfer Carriage- Accessory to the Sterilizer, Steam
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Devices)·Z-0604-2020·2019-12-11
Steris Eagle 3000 Sterilizer Recall Due to Incorrect Safety Valve
Steris is recalling 236 Eagle 3000 Small Steam Sterilizers because the preventive maintenance kit may contain an incorrect pressure safety valve.
Product
Eagle 3000 Sterilizer, small steam sterilizer. Product Usage: The Eagle 3000 Small Sterilizer is designed for sterilization of certain materials used in healthcare facilities, and are available in two configurations: Gravity designed for sterilization of non-porous, heat- and…
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0560-2020·2019-12-11
QuVa Pharma Recalls Fentanyl Syringes Due to Glass Particulate Matter
QuVa Pharma is recalling fentanyl 250 mcg/5 mL syringes due to the presence of glass particulate matter. The recall is nationwide.
Product
fentaNYL 250 mcg/5 mL (50 mcg/mL), 5 mL Syringe, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1098-44
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0548-2020·2019-12-11
QuVa Pharma Recalls Fentanyl and Ropivacaine Infusions Due to Particulate Matter
QuVa Pharma is recalling specific lots of fentanyl and ropivacaine infusions due to the presence of particulate matter, including potential glass particles.
Product
fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride 100 mL CADD, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478NDC 70092-1259-75
Category
Drug
Distribution
Distributed nationwide
HighCPSC·20039·2019-12-11
Profile Design Recalls Carbon Aerobars Due to Crash Hazard
Profile Design is recalling Aeria Ultimate carbon aerobars because they can crack and break, causing riders to lose control and crash.
Product
Aeria Ultimate carbon aerobars
Category
Consumer Product
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0557-2020·2019-12-11
QuVa Pharma Recalls Fentanyl and Bupivacaine Injection Due to Particulate Matter
QuVa Pharma is recalling fentanyl and bupivacaine injection products due to the presence of particulate matter, specifically potential glass particles.
Product
fentaNYL 200 mcg/100 mL (2 mcg/mL) 0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL) in 0.9% Sodium Chloride, 100 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1202-75
Category
Drug
Distribution
Distributed nationwide
HighNHTSA·19V882000·2019-12-11
Indian Recalls 2019 Motorcycles Due to Defective Circuit Breaker
Indian Motorcycle is recalling 5,474 2019 models because a defective circuit breaker may cause sudden engine stalls, increasing crash risk.
Product
INDIAN — INDIAN CHIEFTAIN, ROADMASTER, SPRINGFIELD, SPRINGFIELD DARK HORSE
Category
Vehicle
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0533-2020·2019-12-11
Fagron Recalls LETS GEL Kits Due to Microbial Contamination
Fagron, Inc. is recalling 11,912 kits of LETS GEL Convenience Packs due to microbial contamination of the non-sterile product.
Product
LETS GEL KIT Convenience Pack (To prepare 100 mL LETS GEL), Contains: LETS Powders for Gel: Lidocaine Hydrochloride - 4 g, Ephinephrine Bitartrate - 180 mg, Tetracaine Hydrochloride - 500 mg, Sodium Metabisulfite - 75 mg, SuturaGel Methlcellulose Base; RX Only, For Prescription…
Category
Drug
Distribution
Distributed nationwide
HighNHTSA·19V878000·2019-12-11
Porsche Recalls 2020 911 Carrera Models for Hazard Light Software Error
Porsche is recalling 2020 911 Carrera models because a software error may prevent hazard warning lights from functioning, increasing crash risk.
Product
PORSCHE — PORSCHE 911 CARRERA
Category
Vehicle
Distribution
Distributed nationwide
HighFDA (Devices)·Z-0598-2020·2019-12-11
Allergan Recalls XEN Gel Stent Due to Residual Polishing Compounds
Allergan is recalling XEN Gel Stent implants because residual polishing compounds on the injector needle may transfer to the patient's eye, causing irritation or inflammation.
Product
XEN Gel Stent, REF 5513-001(US Model), Sterile, RX Only, (01)10888628032439 ; Other Model Numbers: 5507-001(Global Model) and 5517-001(Australia model) Implant for glaucoma treatment.
Category
Medical Device
Distribution
Distributed nationwide
HighNHTSA·19V877000·2019-12-11
Toyota Recalls Corolla and C-HR Vehicles for Rear Seat Belt Defect
Toyota is recalling 2019-2020 Corolla, Corolla Hybrid, and C-HR vehicles because the rear seat belt locking mechanism may not function correctly, increasing injury risk in crashes.
Product
TOYOTA — TOYOTA COROLLA HYBRID, COROLLA, C-HR
Category
Vehicle
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0553-2020·2019-12-11
QuVa Pharma Recalls Fentanyl Infusion Bags Due to Glass Particulates
QuVa Pharma is recalling fentanyl infusion bags because they may contain glass particulates. The affected product is distributed nationwide.
Product
fentaNYL 2500 mcg/250 mL (10 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1093-37
Category
Drug
Distribution
Distributed nationwide